Results 201 to 210 of about 59,240 (301)

Weighted prevalence of biochemically verified substance use in healthy adolescents across the USA

Addiction, EarlyView.
Abstract Background and aims Adolescent substance use is a significant public health concern, though the scope of the problem is difficult to ascertain given reliance on self‐reported substance use information. Recent, large cohort studies in adolescents and young adults suggest underreporting of substance use.
Natasha E. Wade, Yajuan Si, Susan F. Tapert, Janosch Linkersdörfer, Krista M. Lisdahl, Hailley R. Moore, Laila Tally, Biplabendu Das, Marilyn A. Huestis, Alexander L. Wallace, Ryan M. Sullivan, Veronica Szpak, Le Zhang, Laura Ziemer, Wesley K. Thompson   +14 more
wiley   +1 more source

Post-legalization rise in German medical cannabis interest: evidence from Google trends as surrogate marker. [PDF]

J Cannabis Res
Kirchberger MC.
europepmc   +1 more source

Alcohol consumption and cognitive function: A systematic review and dose–response meta‐analysis of 20 cohort studies

Addiction, EarlyView.
Abstract Background and aims Amid ongoing debate on whether low‐to‐moderate alcohol consumption reduces cardiovascular risk, studies examining the association between alcohol consumption and cognitive function have reported inconsistent results. To quantitatively assess this association, we conducted a dose–response meta‐analysis of cohort studies ...
Sooyeun Choi, Youjin Je
wiley   +1 more source

Medical cannabis legalization and the use of illicit drugs, alcohol, and tobacco. [PDF]

J Cannabis Res
Al Hallaj H, Barakat Z.
europepmc   +1 more source

Risks of alcohol–energy drink co‐consumption: Patterns, correlates and psychological outcomes in youth

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives This study examined the prevalence of alcohol mixed with energy drinks (AmED) among Spanish adolescents and young adults and analyzed its associations with sociodemographic factors, substance use, and mental health.
Roberto Secades‐Villa, Clara Iza‐Fernández, Ángel García‐Pérez, Layla Alemán‐Moussa, Alba González‐Roz   +4 more
wiley   +1 more source

Medical Cannabis Formulations, Administration Routes, and Dosing: Perspectives of Patients With Cancer Who Consume. [PDF]

Clin Ther
Nayak MM, Chai PR, Tung S, Revette A, Braun IM.   +4 more
europepmc   +1 more source

Do motives for and contexts of cannabis use interact to predict heavy cannabis use at the event‐level?

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Motives for and contexts of cannabis use (CU) are typically examined as independent characteristics of CU events in ecological momentary assessment (EMA) studies. However, theories posit that some combinations of motives and contexts (e.g., using to cope in a solitary setting) may contribute to heavier substance use ...
Christina Dyar, Elise Green, Christine M. Lee   +2 more
wiley   +1 more source

Medical Cannabis for Best Supportive Care of Patients Affected by Cancers of the Head and Neck: A Narrative Review. [PDF]

In Vivo
Perri F, Marciano ML, Zotta A, Pontone M, Piccirillo A, Casale M, DI Filippo P, Sarno MR, D' Aniello R, Cascella M, Maiolino P.   +10 more
europepmc   +1 more source

Extended‐release buprenorphine in adults with opioid use disorder involving poppy seed tea: An 18‐month retrospective case series

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Poppy seed tea (PST) contains unpredictable opioid concentrations, destabilising tolerance and increasing overdose risk. Extended‐release buprenorphine (BUP‐XR) provides sustained coverage without daily dosing. Methods Eighteen‐month follow‐up of adults (N = 3) with opioid use disorder (OUD) involving PST in Australia.
John McMaster, Saumiya Seshakumaran, Hesitha Abeysundera, Isha Tipirneni, Rita Hormiz   +4 more
wiley   +1 more source

The Persistence of Stigma and Other Challenges Experienced by Medical Cannabis Users: A Thematic Synthesis of Qualitative Studies. [PDF]

Med Cannabis Cannabinoids
Breuning M, Nie J, Schlesinger M, Smith L, Lavie-Ajayi M, Babinski S, Law S.   +6 more
europepmc   +1 more source